Ajanta Pharma Q1 profit up 29% at ₹148 crore

PTI New Delhi | Updated on July 30, 2020

Ajanta Pharma on Thursday reported 28.90 per cent rise in consolidated net profit to ₹147.76 crore for the quarter ended June 30 mainly on account of robust exports.

The company had posted a net profit of ₹114.63 crore for the year-ago same period, the drug firm said in a filing to BSE.

Revenue from operations surged to ₹668.20 crore during the quarter under review from ₹611.94 crore in the same period of 2019-20, it added.

Total export sales in the quarter were at ₹483 crore as against ₹404 crore in the year-ago period, registering a growth of 19 per cent, the company said.

Shares of Ajanta Pharma settled at ₹1,512.15 apiece, up 1.52 per cent from the previous close on BSE.

Published on July 30, 2020

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor